Get In Touch

Urological Disorders Treatment Market

The developing computing technology for urine diagnostics, the ageing population, and rising frequency of urinary tract infections are all likely to contribute to the growth of the global urological disorders treatment market. However, the absence of product knowledge in developing countries, as well as the side effects linked with medicine, is estimated to limit the market's development to some extent The global urinary tract infection treatment market is projected to benefit from the increasing research and development activities carried on in the treatment of UTIs.

The urinary tract refers to a drainage system inside the human body that is responsible for emptying urine. The urine bladder, kidneys, and ureters are all part of the urinary system. Urinary tract infections, bladder control difficulties, kidney stones, and prostate problems are all urologic illnesses or conditions. Some urological diseases are temporary, while others persist for a long period. Urological diseases are quite common and extensive. They've been reported all around the world. They have a profound effect on the mental and physical wellbeing of millions of people. Females are affected more than males, and the disease's prevalence rises with age, which is expected to accentuate demand in the global urological disorders treatment market in the near future.

Global Urological Disorders Treatment Market – Introduction

The urinary tract is a drainage system of the human body, which is meant for urine removal. The urinary tract includes the ureters, the kidneys, and the urinary bladder. Urologic conditions or diseases include kidney stones, prostate issues, urinary tract infections, and bladder control issues. Certain urological disorders last only for a short time, while others last for a long time. Urological disorders are highly prevalent and widespread. They have been reported throughout the globe. They make an impact on the lives of millions of individuals causing severe influence on their emotional and physical health. This disease affects females more than males and its incidence increases with age. 

Global Urological Disorders Treatment Market – Competition Landscape

Boston Scientific Corporation

Founded in 1976, Boston Scientific Corporation develops, manufactures, and markets medical devices worldwide for use in multiple medical intervention specialties. It operates through three segments: MedSurg, Rhythm & Neuro, and Cardiovascular. Boston Scientific partners with urologists to continuously promote quality of patient care with innovative alternatives for urology. The company offers a wide range of treatment options for urological disorders such as stone management, benign prostatic hyperplasia (BPH) management, erectile restoration, and male continence. 

Identify the key factors that will drive your company’s growth. Request a brochure of this report here


Incorporated in 1999, Sanofi-Aventis US LLC, a subsidiary of Sanofi, offers products for insulin pens. Sanofi-Aventis US LLC engages in the research, development, manufacture, and marketing of products for cardiovascular diseases, cancer, diabetes, and rare diseases. The company offers branded drugs, such as Libtayo, Jevtana, and Taxotere, for treatment of urological disorders. 

Astellas Pharma Inc.

Established in 2005, Astellas Pharma Inc. is a Japan-based company primarily engaged in the research, development, manufacture, and sale of pharmaceutical products. The company is involved in the manufacture and sale of pharmaceutical products in Japan, the U.S., Europe, China, South Korea, Taiwan, and other markets through its subsidiaries. Its key products include an immunosuppressive drug called Prograf, an overactive bladder agent called Vesicare, an ointment for atopic dermatitis called Protopic, Harnal, a product for prostatic and urethral smooth muscles, and an antimycotic agent called Funguard. 

Key players operating in the global urological disorders treatment market include Boston Scientific Corporation, Sanofi, Astellas Pharma Inc. Johnson & Johnson (Janssen Global Services, LLC), Pfizer Inc., ALLERGAN, Abbott, Merck & Co., Inc., Takeda Pharmaceutical Company Limited, Becton, Dickinson and Company, Intuitive Surgical, KARL STORZ SE &Co. KG, Richard Wolf GmbH, Fresenius Medical Care, Cook Medical, Olympus Corporation, Siemens Healthineers, Stryker, Braun Melsungen AG, Baxter International Inc., and Medtronic. 

Expanding operations in future? To get the perfect launch ask for a custom report here 

Global Urological Disorders Treatment Market – Dynamics

Increase in demand for minimally invasive products across the globe to propel global urological disorders treatment market

Presence of a large pool of patients with urinary illnesses and other symptoms is anticipated to drive the global urology disorders treatment during the forecast period. This high growth rate of the market is attributable to rise in the adoption of urological devices, easy availability of urological devices, and increased demand for minimally invasive products throughout the globe. 

Increasing prevalence of urinary tract infections to boost global urological disorders treatment market

Urinary tract infections (UTIs) are the most common bacterial infections that affect both young and old individuals. This infection generally affects one or more parts of the urinary system and it is especially prevalent among women, with the rate of prevalence of about 1% among college-going girls and 4% among women in child-bearing age. Moreover, developing healthcare infrastructure in nations with high growth potential, increasing healthcare spending per capita, and rise in the number of patients suffering from urological disorders every year are major factors projected to drive the global urological disorders treatment market from 2019 to 2027. 

Global Urological Disorders Treatment Market – Segmentation

The global urological disorders treatment market can be segmented in terms of:

  • Treatment
    • Therapeutics
    • Devices by Urological Disorder Type
  • Application
  • End-user

Global Urological Disorders Treatment Market, by Treatment

In terms of treatment, the global urological disorders treatment market can be divided into:

  • Therapeutics
    • Anticholinergic/Antispasmodic agents
    • Skeletal Muscle Relaxants
    • Antidepressants
    • Alpha Blockers
    • Others
  • Devices by Urological Disorder Type
    • Urinary Incontinence
      • Male Slings
      • Urinary Catheters
      • Artificial Urinary Sphincters
      • Urinary Drainage Bags
      • Others
    • Urinary Stone Treatment Devices
      • Retrieval Devices
      • Ureteral Stents
      • Extracorporeal Shockwave Lithotripsy
      • Others
    • Dialysis Equipment
      • Hemodialysis
      • Peritoneal Dialysis
      • Others
    • Others

Global Urological Disorders Treatment Market, by Application

Based on application, the global urological disorders treatment market can be classified into:

  • Benign Prostatic Hyperplasia (BPH)
  • Prostate Cancer
  • Urinary Incontinence
  • Kidney/Bladder Stone
  • Erectile Dysfunction
  • Others

Global Urological Disorders Treatment Market, by End-user

In terms of end-user, the global urological disorders treatment market can be divided into:

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Others

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis

The regional analysis covers:

  • North America (U.S. and Canada)
  • Latin America (Mexico, Brazil, Peru, Chile, and others)
  • Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
  • Eastern Europe (Poland and Russia)
  • Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
  • Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

  • A complete backdrop analysis, which includes an assessment of the parent market
  • Important changes in market dynamics
  • Market segmentation up to the second or third level
  • Historical, current, and projected size of the market from the standpoint of both value and volume
  • Reporting and evaluation of recent industry developments
  • Market shares and strategies of key players
  • Emerging niche segments and regional markets
  • An objective assessment of the trajectory of the market
  • Recommendations to companies for strengthening their foothold in the market   

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.  

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.


Urological Disorders Treatment Market

Pre Book